
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.47 | -9.07335907336 | 5.18 | 5.47 | 4.59 | 137064 | 4.97526755 | CS |
4 | 0.85 | 22.0207253886 | 3.86 | 5.47 | 3.81 | 181821 | 4.6057236 | CS |
12 | -0.1 | -2.079002079 | 4.81 | 5.47 | 3.55 | 249725 | 4.46733461 | CS |
26 | -5.09 | -51.9387755102 | 9.8 | 11.1 | 3.55 | 340929 | 5.72844443 | CS |
52 | -7.31 | -60.8153078203 | 12.02 | 16.11 | 3.55 | 297063 | 8.76942879 | CS |
156 | -7.15 | -60.2866779089 | 11.86 | 20.9 | 2.7 | 369380 | 8.70164564 | CS |
260 | -36.45 | -88.556851312 | 41.16 | 55.36 | 2.7 | 349908 | 14.3046459 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions